XenoPort生物制药的公告
内部交易: 2012-01-13,SVP & CCO,Angotti Vincent ,期权,7500普通股, $0.00
内部交易: 2012-01-13,CEO,Barrett Ronald W ,期权,26250普通股, $0.00
内部交易: 2012-01-13,SVP, CAO, GC and secretary,Bosko Gianna M ,期权,7000普通股, $0.00
内部交易: 2012-01-13,SVP & CCO,Angotti Vincent ,期权,7500普通股, $0.00
内部交易: 2012-01-13,CEO,Barrett Ronald W ,期权,26250普通股, $0.00
内部交易: 2012-01-13,SVP, Preclinical Development,Cundy Kenneth C ,期权,7500普通股, $0.00
内部交易: 2012-01-13,SVP, CAO, GC and secretary,Bosko Gianna M ,期权,7000普通股, $0.00
内部交易: 2012-01-13,SVP, Finance and CFO,Harris William G ,期权,7500普通股, $0.00
内部交易: 2012-01-13,SVP, Development,Savello David R ,期权,6250普通股, $0.00
内部交易: 2012-01-13,SVP, Preclinical Development,Cundy Kenneth C ,期权,7500普通股, $0.00